— FDA Cleared IND Application for STAR-0215 for the Treatment of Hereditary Angioedema — — Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects Initiated, Preliminary Results Anticipated by Year-End 2022 — — Company to Host a Virtual R&D Day on September 30 — BOSTON–(BUSINESS WIRE)–Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for … [Read more…]
Strong second quarter sales of $2.2 billion, up 5%, or 10% constant currency (cc) Second quarter earnings of $0.30 per diluted share, down 3%, or up 34% cc Second quarter core earnings of $0.63 per diluted share, up 13%, or 30% cc Updated 2022 full year outlook reflects strong underlying operational performance, impacted by strength … [Read more…]
Strong second quarter sales of $2.2 billion, up 5%, or 10% constant currency (cc) Second quarter earnings of $0.30 per diluted share, down 3%, or up 34% cc Second quarter core earnings of $0.63 per diluted share, up 13%, or 30% cc Updated 2022 full year outlook reflects strong underlying operational performance, impacted by strength … [Read more…]
Innovative integrated service model will strengthen supply chain resiliency throughout Allina Health’s hospital and clinical care network, improving care delivery for providers and patients Partnership leverages Owens & Minor expertise, technology and solutions to create a unique, customized supply chain solution with greater visibility, transparency and control for Allina Health MINNEAPOLIS & RICHMOND, Va.–(BUSINESS WIRE)–Owens … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session … [Read more…]
New ARCT-154 clinical booster data demonstrate promising durability; 44- and 39-fold increases in neutralizing antibody response against Omicron BA.1 and BA.2 at Day 91 New cold chain data for Arcturus’ lyophilized vaccine platform shows favorable stability, shipping, and storage advantages European Commission grants Orphan Medicinal Product Designation to ARCT-810, a novel mRNA candidate for ornithine … [Read more…]
ROCKVILLE, Md.–(BUSINESS WIRE)–BioMarker Strategies today announced that the journal CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS has published a manuscript by the Company’s scientists entitled “Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response”. The manuscript describes the company’s progress in identifying predictive dynamic biomarkers to help identify the subset of patients with head … [Read more…]
SANTA MONICA, Calif.–(BUSINESS WIRE)–SimplePractice, an EngageSmart (NYSE: ESMT) solution and industry-leading platform simplifying the health and wellness experience, has been named the winner of a Gold Stevie® Award in the Health, Wellness, and Safety Solution Provider of the Year category in the seventh annual Stevie Awards for Great Employers. The Stevie Awards for Great Employers … [Read more…]
Salucro report reveals nearly half of all patients value the ability to choose their communication channel the most. PHOENIX–(BUSINESS WIRE)–Salucro Healthcare Solutions, a leading healthcare payment technology company, today released the results of its 2022 Trends in Patient Communications Report, a report that can help healthcare providers understand how patient communication preferences have changed and … [Read more…]
New brand encompasses company’s expansion of services and product offerings beyond prior authorizations Reiterates mission to improve healthcare transparency and access for patients, and streamline diagnostic processes for providers FALLS CHURCH, Va.–(BUSINESS WIRE)–CMT Solutions, a healthcare technology company and market leader in molecular diagnostic patient access (“the Company”), today announced that it has rebranded to … [Read more…]
